Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Sebocytes play a key role in controlling androgen levels in human skin.

Male pattern baldness involves genetics, hormones, and needs better treatments.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Probiotic bacteria improved skin and hair health in aged mice.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Minoxidil and finasteride effectively treat hair loss.

Hair follicle regeneration needs special conditions and young cells.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Some common medications can harm male fertility, but many effects can be reversed.

Prolactin affects when mice shed and grow hair.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.